Recent shift from single dose to double dose apheresis is indicative of the high demand for apheresis procedures among patients suffering from chronic diseases. Leading industry players are taking calculated growth measures to expand application of the therapeutic apheresis procedure, which is currently used as the first line and supportive therapy in the treatment of over 87 diseases, as found by the American Society for Apheresis (ASFA).
However, lack of availability of donors and concerns regarding histocompatibility could create negative sentiments among patients, inadvertently impeding revenue potential of the apheresis market to a certain extent. Defying all odds though, the apheresis market is projected to progress at an impressive CAGR of ~10% during the forecast period (2020 - 2025), as noted by Fact.MR in its latest study on the market.
Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global apheresis market, presenting historical demand data (2015-2019), and forecast statistics for the period of 2020-2025. The study divulges compelling insights on the apheresis market on the basis of end user (hospitals and blood collection centres), technology (centrifugation and membrane filtration), procedure (plasmapheresis, photopheresis, LDL apheresis, plateletpheresis, leukapheresis, erythrocytapheresis, and others), product (devices and disposables), and application (renal diseases, neurology, haematology, cancer, autoimmune diseases, cardiovascular diseases, and others), across five major regions.
Get Sample Copy With Impact Analysis Of COVID-19 Of Market Report – https://www.factmr.com/connectus/sample?flag=Srep_id=4350
Apheresis Market - Scope of the Study:
Fact.MR, in its recently published research report on the apheresis market, offers actionable intelligence and key winning strategies for stakeholders in the global apheresis market.
This exclusive study provides rare and relevant insights into weighted dynamics, which directly or indirectly influence the growth of the apheresis market during the forecast period (2020 - 2025).
With the help of key insights offered by this exclusive study, stakeholders will gain a brief idea regarding the growth of the apheresis market, and will be able to make informed business decisions.
c The report also measures the impact of each of these dynamics to estimate the size of the apheresis market for the given period.
High Entry Barrier in Apheresis Market; Competition Continues to Intensify:
The competition is high in the apheresis market, and is likely to intensify in the future, as the number of centres offering apheresis procedures is increasing. Cost-competitiveness remains a key strategy to maintain or increase share in the apheresis market. Existing players will witness low competition from new market entrants, as these players are well-established in the apheresis market with sound financial reserves, which enables them to easily scale their position. On the other hand, an entry into the apheresis market means high level of investment, sound technical knowledge, and licensing requirements, which is creating entry barriers for new players.
The current strategy of players in the apheresis market involves a scramble towards the Asia Pacific and Latin American markets. Besides inorganic growth, players seek market success by maintaining high research development standards to target multiple applications through their products.
Apheresis Market - Assessment of Key Segments:
Product
- Devices
- Disposables
Application
- Renal Diseases
- Neurology
- Haematology
- Cancer
- Autoimmune Diseases
- Cardiovascular Diseases
- Others (Fibrosis and Diabetes)
Procedure
- Plasmapheresis
- Photopheresis
- LDL Apheresis
- Plateletpheresis
- Leukapheresis
- Erythrocytapheresis
- Others (Lymphapheresis and extracorporeal immunoadsorption)
Technology
- Centrifugation
- Membrane Filtration
End User
- Hospitals
- Blood Collection Centres
- Public
- Private
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East Africa
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive industry 4.0 to healthcare retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: [email protected]
Visit Our Website: https://www.factmr.com
